Catalyst Wire Dossier Catalyst Wire Dossier

Rifaximin (Xifaxan)

rifaximin
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Rifaximin (Xifaxan), covering 2013-04-04 to 2025-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan® [Phase 1]

See pricing